ZAP-X Gyroscopic Stereotactic Radiosurgery Platform Makes Its Australian Debut, Expanding Precision Non-Invasive Brain Radiotherapy

ZAP Surgical, the global leader in non-invasive robotic brain surgery, recently announced that GenesisCare will become the first cancer care provider in Australia to introduce the ZAP-X Gyroscopic Radiosurgery platform. Installation of the device is scheduled to begin this month at the GenesisCare center located at St Vincent's Hospital Sydney in New South Wales, with the first patients expected to receive treatment before the end of this year.

The introduction of the ZAP-X platform will significantly enhance GenesisCare's neuro-oncology diagnostic and treatment capabilities in Sydney, providing it with dedicated stereotactic radiosurgery (SRS) services. Previously, patients receiving SRS treatment relied primarily on cobalt-60-based systems and multi-purpose radiotherapy linear accelerators. With the deployment of ZAP-X, clinicians will have access to a next-generation medical platform designed specifically for non-invasive cranial stereotactic radiosurgery.

Stereotactic radiosurgery (SRS) is a non-invasive and painless treatment modality that has become a breakthrough option for treating a variety of primary and metastatic brain tumors, as well as specific conditions of the brain, head, and neck. As an alternative to open surgery, SRS can typically be completed in a single outpatient visit, with many patients able to resume normal activities the same day. Dr. Sandy Sampaio, a radiation oncologist at GenesisCare, stated that the introduction of ZAP-X brings advanced non-invasive precision radiotherapy technology to Australia, effectively protecting patients' critical brain structures while improving their quality of life.

Yair Bauer, Vice President of ZAP Surgical Asia-Pacific and President of its Japan subsidiary, noted that the Sydney project represents an important milestone in the company's efforts to expand advanced cranial radiosurgery technology across the Asia-Pacific region. GenesisCare's continued investment in this cutting-edge technology reflects a shared commitment to improving patient outcomes and making world-class non-invasive brain treatment more accessible to Australian patients.

The ZAP-X system is renowned for its innovative design, utilizing unique gyroscopic mobility to deliver radiation beams from thousands of potential angles, precisely focusing radiation on target lesions. This cutting-edge approach is designed to improve clinical outcomes by minimizing unnecessary radiation exposure to healthy brain tissue and critical structures such as the brainstem, eyes, and optic nerves, helping to preserve patients' cognitive function and quality of life.

In addition, ZAP-X is the world's first and only SRS technology that does not require a radiation-shielded vault (Vault-free). It eliminates the need for expensive concrete shielding bunkers and can be installed in more convenient, patient-friendly environments. At the same time, ZAP-X uses a modern medical linear accelerator to replace traditional cobalt-60 radioactive sources, eliminating the logistical and safety burdens associated with radioisotope management and disposal.

This installation project at St Vincent's Hospital Sydney further demonstrates GenesisCare's commitment to continuously investing in advanced technology to improve patient outcomes. With the support of specialized medical technology distributor Alorium, the introduction of ZAP-X marks an important step forward in providing patients in New South Wales and surrounding regions with access to world-class cranial stereotactic radiosurgery services.